Disparities in access to reperfusion therapies among patients with STEMI of the non-metropolitan and metropolitan region of Aracaju

• Autor(a) principal: Arcelino, Larissa Andreline Maia
• Data de Publicação: 2022
• Outros Autores: Oliveira, Jussiely Cunha, Lima, Ticiane Clair Remacre Munareto, Oliveira, Jeferson Cunha, Barreto, Íkaro Daniel de Carvalho, Oliveira, Laís Costa Souza, Ramos, Maria Júlia Oliveira, Barreto-Filho, José Augusto
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/26505
• topic: Myocardial infarction; Myocardial reperfusion; Disparities in health care.; Infarto del miocardio; Reperfusión miocárdica; Disparidades en atención de salud.; Infarto do miocárdio; Reperfusão miocárdica; Disparidades em assistência à saúde.

Aim: To compare the celerity of hospital access with percutaneous coronary intervention (PCI), use of primary PCI and 30-day mortality among patients with STEMI who initiated symptoms in the non-metropolitan region with those who started in the metropolitan region of the state of Aracaju. Method: A quantitative cohort study using data from the VICTIM registry from December 2014 to October 2017. A significance level of 5% was adopted (p<0,05). Findings: 878 patients participated in the study, of which 382 started the symptoms in the metropolitan region and 496 in the non-metropolitan region. The latter region traveled more distances (104 ± 58.4km vs. 16 ± 49.3km, p <0.001), passed more than 1 institution (96% vs. 73%, p <0.001), presented greater delay to the hospital (11h [7-26] vs. 7h [3-17], p <0.001) and therefore performed less primary PCI (45% vs. 59%, p <0.001). It was also observed that those from the non-metropolitan region had a higher chance of death at 30 days (OR 1.84, 95% CI, 1.12 to 3.04, p = 0.016). Conclusion: Disparities in access, use of primary PCI, and 30-day mortality rates observed among the groups analyzed. These findings may help to better delineate the logistics of access to reperfusion therapies in Sergipe.